Trial intelligence / Profile preview

Low-dose prednisolone in elderly rheumatoid arthritis

2015-002729-21Phase 4Completed

Sponsor
VU University Medical Center
Start
Feb 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Prednisolone add-on with Placebo add-on (2 arms). Primary endpoint: Time-averaged DAS28. Started Feb 2016; status: completed.

02

Drugs

prednisolone
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2015-002729-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002729-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call